IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines

Cytokines of the interleukin-1 (IL-1) family, such as IL-1α/β and IL-18, have important functions in host defense, immune regulation, and inflammation. Insight into their biological functions has led to novel therapeutic approaches to treat human inflammatory diseases. Within the IL-1 family, IL-1α/...

Full description

Saved in:
Bibliographic Details
Published inImmunity (Cambridge, Mass.) Vol. 23; no. 5; pp. 479 - 490
Main Authors Schmitz, Jochen, Owyang, Alexander, Oldham, Elizabeth, Song, Yaoli, Murphy, Erin, McClanahan, Terril K., Zurawski, Gerard, Moshrefi, Mehrdad, Qin, Jinzhong, Li, Xiaoxia, Gorman, Daniel M., Bazan, J. Fernando, Kastelein, Robert A.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.11.2005
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cytokines of the interleukin-1 (IL-1) family, such as IL-1α/β and IL-18, have important functions in host defense, immune regulation, and inflammation. Insight into their biological functions has led to novel therapeutic approaches to treat human inflammatory diseases. Within the IL-1 family, IL-1α/β, IL-1Ra, and IL-18 have been matched to their respective receptor complexes and have been shown to have distinct biological functions. The most prominent orphan IL-1 receptor is ST2. This receptor has been described as a negative regulator of Toll-like receptor-IL-1 receptor signaling, but it also functions as an important effector molecule of T helper type 2 responses. We report a member of the IL-1 family, IL-33, which mediates its biological effects via IL-1 receptor ST2, activates NF-κB and MAP kinases, and drives production of TH2-associated cytokines from in vitro polarized TH2 cells. In vivo, IL-33 induces the expression of IL-4, IL-5, and IL-13 and leads to severe pathological changes in mucosal organs.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1074-7613
1097-4180
DOI:10.1016/j.immuni.2005.09.015